BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study
Title: | BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study |
---|---|
Authors: | Ezine, Emilien a, b, Da Silva, Angélique c, d, Idoudi, Safa a, Lebbe, Céleste a, b, Chrétien, Basile e, Sassier, Marion c, Alexandre, Joachim f, Dolladille, Charles f, * |
Source: | In Therapies December 2024 |
Database: | ScienceDirect |
FullText | Text: Availability: 0 CustomLinks: – Url: https://www.doi.org/10.1016/j.therap.2024.12.011? Name: ScienceDirect (all content)-s8985755 Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edselp&genre=article&issn=00405957&ISBN=&volume=&issue=&date=20250101&spage=&pages=&title=Therapies&atitle=BRAF%20and%20MEK%20inhibitors%20rechallenge%20after%20an%20adverse%20drug%20reaction%20in%20patients%20with%20cancer%3A%20A%20pharmacovigilance%20cohort%20study&aulast=Ezine%2C%20Emilien&id=DOI:10.1016/j.therap.2024.12.011 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edselp DbLabel: ScienceDirect An: S0040595725000010 RelevancyScore: 1179 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 1179.40441894531 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ezine%2C+Emilien%22">Ezine, Emilien</searchLink> <superscript>a, b</superscript><br /><searchLink fieldCode="AR" term="%22Da+Silva%2C+Angélique%22">Da Silva, Angélique</searchLink> <superscript>c, d</superscript><br /><searchLink fieldCode="AR" term="%22Idoudi%2C+Safa%22">Idoudi, Safa</searchLink> <superscript>a</superscript><br /><searchLink fieldCode="AR" term="%22Lebbe%2C+Céleste%22">Lebbe, Céleste</searchLink> <superscript>a, b</superscript><br /><searchLink fieldCode="AR" term="%22Chrétien%2C+Basile%22">Chrétien, Basile</searchLink> <superscript>e</superscript><br /><searchLink fieldCode="AR" term="%22Sassier%2C+Marion%22">Sassier, Marion</searchLink> <superscript>c</superscript><br /><searchLink fieldCode="AR" term="%22Alexandre%2C+Joachim%22">Alexandre, Joachim</searchLink> <superscript>f</superscript><br /><searchLink fieldCode="AR" term="%22Dolladille%2C+Charles%22">Dolladille, Charles</searchLink> <superscript>f, *</superscript> – Name: TitleSource Label: Source Group: Src Data: In <searchLink fieldCode="JN" term="%22Therapies%22">Therapies</searchLink> December 2024 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edselp&AN=S0040595725000010 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.therap.2024.12.011 Languages: – Code: eng Text: English Titles: – TitleFull: BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ezine, Emilien – PersonEntity: Name: NameFull: Da Silva, Angélique – PersonEntity: Name: NameFull: Idoudi, Safa – PersonEntity: Name: NameFull: Lebbe, Céleste – PersonEntity: Name: NameFull: Chrétien, Basile – PersonEntity: Name: NameFull: Sassier, Marion – PersonEntity: Name: NameFull: Alexandre, Joachim – PersonEntity: Name: NameFull: Dolladille, Charles IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: December 2024 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 00405957 Titles: – TitleFull: Therapies Type: main |
ResultId | 1 |